FDA IMPORT SEIZURE AUTHORITY CHALLENGED
This article was originally published in The Tan Sheet
Executive Summary
FDA IMPORT SEIZURE AUTHORITY CHALLENGED in an April 18 decision by a New Orleans federal judge that the agency was required to give an importer the opportunity to export mushrooms thought to be misbranded or adulterated before seizing them. The decision could have an effect on other FDA-regulated products such as drugs, dietary supplements, cosmetics and devices. The importer claims it has the right to re-export the products because they had not cleared U.S. Customs at the time they were seized.